Truxima 500 mg/50 mL (10 mg/mL) single-dose vial Images
Generic Name: rituximab
This medication has been identified as Truxima 500 mg/50 mL (10 mg/mL) single-dose vial and is used for Granulomatosis with Polyangiitis, Follicular Lymphoma, Non-Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia, and Microscopic Polyangiitis. It belongs to the drug class CD20 monoclonal antibodies and is not a controlled substance.
Images of medication
Truxima
- Generic Name
- rituximab
- Strength
- 500 mg/50 mL (10 mg/mL) single-dose vial
- Availability
- Prescription only
- Drug Class
- CD20 monoclonal antibodies
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Teva Pharmaceuticals USA, Inc.
- Manufacturer
- Cephalon, Inc.
- National Drug Code (NDC)
- 63459-0104
See also:
More about Truxima (rituximab)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (4)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- FDA approval history
- Drug class: CD20 monoclonal antibodies
- Breastfeeding
- En español
Patient resources
- Truxima drug information
- Truxima (Rituximab Intravenous) (Advanced Reading)
- Truxima (Rituximab-abbs Intravenous) (Advanced Reading)
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.